NCT04808336

Brief Summary

Spondylolisthesis is a serious health condition that is often treated with surgery or pain-relieving lumbar epidural steroids. Patients with persistent and debilitating symptoms who have failed to respond to conservative treatment should consider surgery. Objectives: The aim of this study was to compare the therapeutic efficacy of three ultrasound guided PRP injections of the facet joint capsule to surgical procedures in patients with degenerative spondylolisthesis G1 and their effect on neurogenic pain relief and functional improvement over a one-year follow-up period. Methods: A one-year prospective randomised comparative clinical trial was performed on 60 patients with degenerative spondylolisthesis G1 who were randomly assigned to one of two groups: Group 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals, and Group 2: thirty patients underwent surgery. They were exposed to clinical neuropsychological testing.They were assessed for pain and function using clinical neurological assessments, VAS (Visual Analogue Scale), FRI (Functional Rating Index), Roland Morris, and ODI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 26, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2020

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 26, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 14, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 22, 2021

Completed
Last Updated

March 22, 2021

Status Verified

March 1, 2021

Enrollment Period

1.1 years

First QC Date

March 14, 2021

Last Update Submit

March 18, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • 1-Visual analogue scale. ,

    VAS Visual analogue scale: According to the VAS, the pain severity was calculated by the patients on a scale of 0 (no pain) to 10 (agonising pain)

    12 months

  • 2-The Persian Functional Rating Index (FRI )

    The Persian Functional Rating Index (FRI ), which is an accurate and valid instrument that contains 10 items that measure both pain and function, with an impairment score ranging from 0% (no disability) to 100% (severe disability) 2- The Persian Functional Rating Index (FRI ), which is an accurate and valid instrument that contains 10 items that measure both pain and function, with an impairment score ranging from 0% (no disability) to 100% (severe disability)

    12 months

Secondary Outcomes (2)

  • Oswestry Disability Index (ODI) for low back pain

    12 months

  • The Roland-Morris questionnaire

    12 months

Study Arms (2)

PRP injection group

ACTIVE COMPARATOR

Group 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals,

Other: PRP injection.

surgical group..

ACTIVE COMPARATOR

Group 2: thirty patients underwent surgery

Procedure: fixation surgical procedure

Interventions

Group 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals,

PRP injection group

Group 2: thirty patients underwent surgery

surgical group..

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with degenerative spondylolithesis Grade 1 were diagnosed based on their clinical and radiological image.
  • Patients complained of extreme pain and received medical treatment (NSAIDS) without improvement.

You may not qualify if:

  • Patients with more than two-level pathological lesions and those who had previously
  • Patients undergone lumbar surgery,
  • HCV, HBV infected patients,
  • patients with local abscesses,
  • diabetes mellitus,
  • malignancy, pregnancy,
  • blood disorders (coagulopathy, thrombocytopenia),
  • patients who had previously received local injection of steroid within past 3 weeks
  • Patients who had undergone lumbar surgery,
  • patients with advanced spondylolithesis, disc prolapse,
  • inflammatory or musculoskeletal disorders of the spine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dalia Saif

Shebien Elkom, 11311, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of Rheumatology at faculty of medicine Menoufia University

Study Record Dates

First Submitted

March 14, 2021

First Posted

March 22, 2021

Study Start

March 26, 2019

Primary Completion

May 2, 2020

Study Completion

May 26, 2020

Last Updated

March 22, 2021

Record last verified: 2021-03

Locations